MHRA-101671-PIP01-24

Key Facts

PIPS Key Facts
Active Substance
Active Substance:
  • PEGCETACOPLAN
Invented Name
  • ASPAVELI
  • ASPAVELI
PIP Number MHRA-101671-PIP01-24
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for infusion
Therapeutic area
Therapeutic area:
  • Uro-Nephrology
Conditions / Indications
Conditions / Indications:
  • Treatment of glomerulonephritis and nephrotic syndrome
Route(s) of administration
Route(s) of administration:
  • Subcutaneous use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):PEGCETACOPLAN.pdf
Published Date 02/05/2025